Welcome to Pedagogy   |   Sign In

Gene that makes bacteria resistant to last-resort antibiotics found in China

A new gene that makes bacteria highly resistant to a last-resort class of antibiotics has been found in people and pigs in China - including in samples of bacteria with epidemic potential, a new study has found. The discovery was described as "alarming" by scientists, who called for urgent restrictions on the use of polymyxins — a class of antibiotics that includes the drug colistin and is widely used in livestock farming.

"All use of polymyxins must be minimized as soon as possible and all unnecessary use stopped," said Laura Piddock, a professor of microbiology at Britain's Birmingham University who was not involved in the study.

Researchers led by Hua Liu from the South China Agricultural University, who published their work in the Lancet Infectious Diseases journal, found the gene, called mcr-1, on plasmids — mobile DNA that can be easily copied and transferred between different bacteria.
This suggests "an alarming potential" for it to spread and diversify between bacterial populations, they said.

The team already has evidence of the gene being transferred between common bacteria such as E.coli, which causes urinary tract and many other types of infection, and Klesbsiella pneumoniae, which causes pneumonia and other infections.

This suggests "the progression from extensive drug resistance to pan-drug resistance is inevitable," they said.

"(And) although currently confined to China, mcr-1 is likely to emulate other resistance genes ... and spread worldwide."

The discovery of the spreading mcr-1 resistance gene echoes news from 2010 of another so-called "superbug" gene, NDM-1, which emerged in India and rapidly spread around the world.

Global surveillance essential

Professor Piddock and others said global surveillance for mcr-1 resistance was now essential to try to prevent the spread of polymyxin-resistant bacteria.

China is one of the world's largest users and producers of colistin for agriculture and veterinary use.

Worldwide demand for the antibiotic in agriculture is expected to reach almost 12,000 tons per year by the end of 2015, rising to 16,500 tons by 2021, according to a 2015 report by QYResearch.

For the China study, researchers collected bacteria samples from pigs at slaughter across four provinces, and from pork and chicken sold in 30 open markets and 27 supermarkets in Guangzhou between 2011 and 2014. They also analyzed bacteria from patients with infections at two hospitals in Guangdong and Zhejiang.

They found a high prevalence of the mcr-1 gene in E coli samples from animals and raw meat. Worryingly, the proportion of positive samples increased from year to year, they said, and mcr-1 was also found in 16 E.coli and K.pneumoniae samples from 1,322 hospitalized patients.

Professor David Paterson and Dr Patrick Harris from the University of Queensland said the links between agricultural use of colistin, colistin resistance in slaughtered animals, colistin resistance in food, and colistin resistance in humans were now complete.

"One of the few solutions to uncoupling these connections is limitation or cessation of colistin use in agriculture," they wrote in a separate commentary in the journal.

"Failure to do so will create a public health problem of major dimensions."
Read the original Reuters article on ABC News by following the link: http://www.abc.net.au/news/2015-11-19/gene-that-makes-bacteria-resistant-to-antibiotics-found-in-china/6954756

For healthcare providers desiring to learn more about intravenous antimicrobial agents available, the latest in research and development of new generations of antibiotics and antibiotic stewardship, take a look at Pedagogy's latest in infusion onine continuing nursing education:

Intravenous Antibiotics Where We Are and Where We're Going- Glycopeptides

Intravenous Antibiotics Where We Are and Where We're Going- ß Lactams

Intravenous Antibiotics Where We Are and Where We're Going- Additional Classifications

These instructional courses have been designed for nurses administering and/or caring for the patient receiving intravenous antibiotics. I.V. antibiotics have been administered for nearly a century but bacterial resistance has forced an ever-increasing arsenal of drugs. In this often- changing landscape, the nurse needs a working knowledge of the antimicrobial agents available, and competency to infuse these medications in all the various administration systems in use today. These courses review each of the classes of intraveous antibiotics, indications for use, proper dosing, potential side effects and proper administration. 

Click on each course title to learn more. Pedagogy offers one of the largest online continuing nursing education catalogs in the field of infusion therapy, to see the entire infusion course catalog click here.

Pedagogy Newsletter
Subscribe to Pedagogy's Quarterly Newsletter


Copyright © 2020 Pedagogy, Inc. All Rights Reserved.

Powered by Kentico